Back to search

Article

Orally Administered EC16 Nanoparticles Attenuate Periodontitis and Cross the Blood–Brain Barrier to Modulate Neuroinflammatory Responses

2026-04-01

Abstract excerpt

Periodontal disease (PD) affects a large proportion of adults and is increasingly associated with systemic inflammation and neurodegenerative risk. However, current therapies have limited efficacy in disrupting biofilms and modulating systemic responses. In this pilot study, we evaluated epigallocatechin-3-gallate-palmitate (EGCG-palmitate or EC16) nanoparticles (NPs), a lipid-soluble derivative of epigallocatechi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3e923537-e6f5-5d0d-81fe-4d71ab533d75
DOI
10.20944/preprints202603.2528.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Orally Administered EC16 Nanoparticles Attenuate Periodontitis and Cross the Blood–Brain Barrier to Modulate Neuroinflammatory ResponsesDOI 10.20944/preprints202603.2528.v1
Select a neighboring publication to make it the new centre.